Net Cash Provided by (Used in) Operating Activities |
-3.59M |
USD |
-6.73% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
4.72M |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
70M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
23.7M |
shares |
+73.9% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.12M |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
11.6M |
USD |
+26.6% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
10.4M |
USD |
+66.5% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
10.4M |
USD |
+66.5% |
Q4 2023 |
FY 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-28.1M |
USD |
-58.5% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
5.23M |
USD |
+58.6% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
30M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
84.1M |
USD |
+40.8% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Share-based Payment Arrangement, Expense |
2.7M |
USD |
+23.8% |
Q2 2024 |
Q2 2024 |
Interest Expense |
6.86K |
USD |
|
Q4 2023 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |